Skip to main content
Log in

Focus on progressive myoclonic epilepsy in Berardinelli-Seip syndrome

  • Brief Communication
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Introduction

Berardinelli-Seip syndrome or congenital generalized lipodystrophy type 2 is a rare genetic disorder characterized by selective loss of subcutaneous adipose tissue associated with peripheral insulin resistance and its complications. Nonprogressive mental retardation, dystonia, ataxia, and pyramidal signs are commonly present, whereas epilepsy has only occasionally been observed.

Case report

We report the case of two sisters, 11 and 18 years old respectively, with an overlapping clinical phenotype compatible with Berardinelli-Seip syndrome and progressive myoclonic epilepsy. Molecular analysis identified an autosomal recessive c.1048C > t;(p(Arg350*)) pathogenic mutation of exon 8 of the BSCL2 gene, which was present in a homozygous state in both patients.

Conclusions

Our paper contributes to further delineate a complex phenotype associated with BSCL2 mutation, underlining how seipin has a central and partially still unknown role that goes beyond adipose tissue metabolism, with a prominent involvement in central nervous system pathology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Patni N, Garg A (2015) Congenital generalized lipodystrophies—new insights into metabolic dysfunction. Nat Rev Endocrinol 11(9):522–534. https://doi.org/10.1038/nrendo.2015.123

    Article  CAS  PubMed  Google Scholar 

  2. Opri R, Fabrizi GM, Cantalupo G, Ferrarini M, Simonati A, Dalla Bernardina B, Darra F (2016) Progressive myoclonus epilepsy in congenital generalized lipodystrophy type 2: report of 3 cases and literature review. Seizure. 42:1–6. https://doi.org/10.1016/j.seizure.2016.08.008

    Article  PubMed  Google Scholar 

  3. Lima JG, Nobrega LH, de Lima NN, do Nascimento Santos MG, Baracho MF, Jeronimo SM (2016) Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophy. Diabetol Metab Syndr 8:23. https://doi.org/10.1186/s13098-016-0140-x

    Article  PubMed  PubMed Central  Google Scholar 

  4. Tseng CF, Ho CS, Chiu NC, Lin SP, Tzen CY, Wu YH (2009) Lafora disease and congenital generalized lipodystrophy: a case report. Kaohsiung J Med Sci 25(12):663–668. https://doi.org/10.1016/S1607-551X(09)70572-8

    Article  PubMed  Google Scholar 

  5. Guillén-Navarro E, Sánchez-Iglesias S, Domingo-Jiménez R, Victoria B, Ruiz-Riquelme A, Rábano A, Loidi L, Beiras A, González-Méndez B, Ramos A, López-González V, Ballesta-Martínez MJ, Garrido-Pumar M, Aguiar P, Ruibal A, Requena JR, Araújo-Vilar D (2013) A new seipin-associated neurodegenerative syndrome. J Med Genet 50(6):401–409. https://doi.org/10.1136/jmedgenet-2013-101525

    Article  CAS  PubMed  Google Scholar 

  6. Serino D, Davico C, Specchio N, Marras CE, Fioretto E (2019) Berardinelli-Seip syndrome and progressive myoclonus epilepsy. Epileptic Disord 21(1):117–121. https://doi.org/10.1684/epd.2019.1038

    Article  PubMed  Google Scholar 

  7. Ebihara C, Ebihara K, Aizawa-Abe M, Mashimo T, Tomita T, Zhao M, Gumbilai V, Kusakabe T, Yamamoto Y, Aotani D, Yamamoto-Kataoka S, Sakai T, Hosoda K, Serikawa T, Nakao K (2015) Seipin is necessary for normal brain development and spermatogenesis in addition to adipogenesis. Hum Mol Genet 24(15):4238–4249. https://doi.org/10.1093/hmg/ddv156

    Article  CAS  PubMed  Google Scholar 

  8. Garfield AS, Chan WS, Dennis RJ, Ito D, Heisler LK, Rochford JJ (2012) Neuroanatomical characterisation of the expression of the Lipodystrophy and motor-neuropathy gene Bscl2 in adult mouse brain. PLoS One 7(9):e45790. https://doi.org/10.1371/journal.pone.0045790

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Sánchez-Iglesias S, Fernández-Liste A, Guillín-Amarelle C, Rábano A, Rodriguez-Cañete L, González-Méndez B, Fernández-Pombo A, Senra A, Araújo-Vilar D (2019) Does seipin play a role in oxidative stress protection and peroxisome biogenesis? New insights from human brain autopsies. Neuroscience 396:119–137. https://doi.org/10.1016/j.neuroscience.2018

    Article  PubMed  Google Scholar 

  10. Kälviäinen R (2015) Progressive myoclonus epilepsies. Semin Neurol 35(3):293–299. https://doi.org/10.1055/s-0035-1552620

    Article  PubMed  Google Scholar 

Download references

Funding

The authors received no funding for this work. The work described has not been published before, and it is not under consideration for publication anywhere else.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Silvia Ferranti.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Its publication has been approved by all co-authors, as well as by the responsible authorities at the institute where the work has been carried out.

Informed consent

Informed consent was obtained from the patient’s parents.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ferranti, S., Lo Rizzo, C., Renieri, A. et al. Focus on progressive myoclonic epilepsy in Berardinelli-Seip syndrome. Neurol Sci 41, 3345–3348 (2020). https://doi.org/10.1007/s10072-020-04418-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04418-1

Keywords

Navigation